Recommendation and upside; We initiate coverage of DMS, a specialist in radiology and bone densitometry which has also started to invest in side-businesses (electronic noses through Alpha Mos, fundamental and applied research on adipose tissue through Stemcis…). The current market capitalisation stands at c. €26m based on a share price of €0.17, but we see significant potential upside (over 70%), with a target price of €0.29, reflecting the company’s sound growth p
07 Jul 2016
Radiology, bone densitometry….and more!
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Radiology, bone densitometry….and more!
Diagnostic Medical Systems (0RIA:LON) | 0 0 0.0%
- Published:
07 Jul 2016 -
Author:
Fabrice Farigoule -
Pages:
34
Recommendation and upside; We initiate coverage of DMS, a specialist in radiology and bone densitometry which has also started to invest in side-businesses (electronic noses through Alpha Mos, fundamental and applied research on adipose tissue through Stemcis…). The current market capitalisation stands at c. €26m based on a share price of €0.17, but we see significant potential upside (over 70%), with a target price of €0.29, reflecting the company’s sound growth p